ETON Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	25 959.00
Średni wolumen	63 919.00
Kapitalizacja rynkowa	93.00M
EPS	$0 ( 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-90.50
ATR14	$0.0120 (0.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-13	Gruber James R.	Buy	144 677	Stock Option (Right to buy)
2024-02-13	Adams Jennifer Mckie	Buy	30 000	Stock Option (Right to buy)
2024-02-13	Brynjelsen Sean	Buy	438 633	Stock Option (Right to buy)
2024-02-13	Casamento Charles J	Buy	30 000	Stock Option (Right to buy)
2024-02-13	Krempa David	Buy	144 677	Stock Option (Right to buy)

INSIDER POWER
56.09
Last 96 transactions
Buy: 4 266 352 \| Sell: 3 981 653

Wolumen Korelacja

Długi: 0.18 (neutral)

Krótki: -0.82 (strong negative)

Signal:(47.184) Neutral

Eton Pharmaceuticals Inc Korelacja

10 Najbardziej pozytywne korelacje
CPSH	0.917
AZ	0.91
ASPS	0.897
NLSP	0.892
RGC	0.89
TTEC	0.888
NDLS	0.887
CLEU	0.886
PRTS	0.886
CASI	0.886

10 Najbardziej negatywne korelacje
DXPE	-0.916
MNMD	-0.905
BNR	-0.904
CTHR	-0.904
CDXC	-0.9
STAA	-0.898
SWBI	-0.897
WHLR	-0.897
KNTK	-0.889
RGLS	-0.889

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Eton Pharmaceuticals Inc Korelacja - Waluta/Towar

-0.12
( neutral )

0.40
( neutral )

0.00
( neutral )

-0.38
( neutral )

0.00
( neutral )

-0.52
( weak negative )

Eton Pharmaceuticals Inc Finanse

Annual	2023
Przychody:	$31.64M
Zysk brutto:	$21.06M (66.56 %)
EPS:	$-0.0365

FY	2023
Przychody:	$31.64M
Zysk brutto:	$21.06M (66.56 %)
EPS:	$-0.0365

FY	2022
Przychody:	$21.25M
Zysk brutto:	$14.32M (67.38 %)
EPS:	$-0.390

FY	2021
Przychody:	$21.83M
Zysk brutto:	$19.21M (87.99 %)
EPS:	$-0.0800

Financial Reports:

No articles found.

Eton Pharmaceuticals Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.